𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Association between plasma hepatocyte growth factor and gefitinib resistance in patients with advanced non-small cell lung cancer

✍ Scribed by Han, Ji-Youn; Kim, Jin Young; Lee, Suk Hyung; Yoo, Nam Jin; Choi, Byung Gil


Book ID
119320574
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
441 KB
Volume
74
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Reaction of plasma hepatocyte growth fac
✍ Hidenori Tanaka; Tatsuo Kimura; Shinzoh Kudoh; Shigeki Mitsuoka; Tetsuya Watanab πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 242 KB

## Abstract Hepatocyte growth factor induces resistance to epidermal growth factor receptor tyrosine kinase inhibitors. It has been hypothesized that epidermal growth factor receptor tyrosine kinase inhibitors administration may influence the levels of plasma hepatocyte growth factor. Patients with